October 12, 2021
The Japanese government will conduct “priority and swift reviews” on US Merck’s oral COVID-19 treatment molnupiravir if it is filed in the country, Health Minister Shigeyuki Goto said on October 12 following the drug’s submission for Emergency Use Authorization in...read more